Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BL, ? 4.1 mm, RC, SLA 10 mm: medical device reports filed with FDA

5,645 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

5,645
device reports naming the brand
0% of all MAUDE reports · about 817 a year
192
reports, 12 months to August 2026
420 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 5,645 reports that name the brand "BL, ? 4.1 mm, RC, SLA 10 mm" (endosseous dental implant), received between August 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

192 reports arrived in the 12 months to August 2026, down 54% from 420 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (72.4%), loss of osseointegration (23.3%) and fracture (3.5%). The patient problems coded most often are tissue damage, fibrosis and pain. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

096191Sep 2021: 191Oct 2021: 85Nov 2021: 55Dec 2021: 1362022Jan 2022: 102Feb 2022: 65Mar 2022: 32Apr 2022: 53May 2022: 33Jun 2022: 27Jul 2022: 66Aug 2022: 55Sep 2022: 59Oct 2022: 100Nov 2022: 131Dec 2022: 1032023Jan 2023: 24Feb 2023: 10Mar 2023: 12Apr 2023: 108May 2023: 165Jun 2023: 159Jul 2023: 123Aug 2023: 117Sep 2023: 69Oct 2023: 69Nov 2023: 130Dec 2023: 442024Jan 2024: 108Feb 2024: 68Mar 2024: 46Apr 2024: 81May 2024: 67Jun 2024: 88Jul 2024: 52Aug 2024: 42Sep 2024: 42Oct 2024: 27Nov 2024: 40Dec 2024: 532025Jan 2025: 30Feb 2025: 24Mar 2025: 29Apr 2025: 30May 2025: 0Jun 2025: 97Jul 2025: 17Aug 2025: 31Sep 2025: 18Oct 2025: 27Nov 2025: 12Dec 2025: 342026Jan 2026: 11Feb 2026: 15Mar 2026: 16Apr 2026: 17May 2026: 15Jun 2026: 9Jul 2026: 11Aug 2026: 7

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

05651,1292019: 60020192020: 89620202021: 1,12920212022: 82620222023: 1,03020232024: 71420242025: 34920252026: 1012026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%5,645
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report99%5,587
Voluntary report0%0
User facility report0%0
Distributor report1%58
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate4,08672.4%62.8%
Loss of osseointegration1,31423.3%22.4%
Fracturea broken bone1963.5%1.6%
Difficult to removethe device was hard to remove50.1%0%
Difficult to insertthe device was hard to insert40.1%0.4%
Unstable40.1%0%
Therapeutic or diagnostic output failure30.1%0%
Unintended movement30.1%0%
Separation failure20%0.1%
Activation, positioning or separation problem10%0%
Positioning problem10%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Tissue damage88515.7%
Fibrosis72912.9%
Painpain, site not specified59210.5%
Inflammationinflammation3616.4%
Hemorrhage/blood loss/bleeding3536.3%
Swelling/ edema2203.9%
Failure of implant1292.3%
Hypersensitivity/allergic reaction771.4%
Abscessa collection of pus751.3%
Numbnessnumbness691.2%
Swellingswelling520.9%
Fistula510.9%
Inadequate osseointegration390.7%
Hyperresponsive to stimuli160.3%
Increased sensitivity110.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBL, ? 4.1 mm, RC, SLA 10 mmProduct code DZEAll MAUDE reports
Reports5,6453,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer99%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BL, ? 4.1 mm, RC, SLA 10 mm reports

How many FDA reports name BL, ? 4.1 mm, RC, SLA 10 mm?

5,645 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 192 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (72.4%), loss of osseointegration (23.3%), fracture (3.5%), difficult to remove (0.1%) and difficult to insert (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (99%) and distributor reports (1%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BL, ? 4.1 mm, RC, SLA 10 mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.